Retrovirhttp://www.unboundmedicine.com/medline/ebm/research/RetrovirUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa.http://www.unboundmedicine.com/medline/ebm/record/19043928/full_citation/Severe_hyperlactataemia_complicating_stavudine_first_line_antiretroviral_therapy_in_South_Africa_Stead D, Osler M, Boulle A, et al. 
Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa. [Journal Article]
Antivir Ther 2008; 13(7):937-43.
Abstract | Full CitationFDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup.http://www.unboundmedicine.com/medline/ebm/record/19043870/full_citation/FDA_notifications__FDA_approved_pediatric_efficacy_supplement_for_Retrovir_syrup_FDA notifications. FDA approved pediatric efficacy supplement for Retrovir syrup. [Newspaper Article]
AIDS Alert 2008 Nov; 23(11):128.
Full CitationRetrovir efficacy supplement approved.http://www.unboundmedicine.com/medline/ebm/record/19043841/full_citation/Retrovir_efficacy_supplement_approved_Retrovir efficacy supplement approved. [News]
AIDS Patient Care STDS 2008 Nov; 22(11):918.
Full Citation | Find Related Articles High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.http://www.unboundmedicine.com/medline/ebm/record/19036752/full_citation/High_rate_of_early_virological_failure_with_the_once_daily_tenofovir/lamivudine/nevirapine_combination_in_naive_HIV_1_infected_patients_Rey D, Hoen B, Chavanet P, et al. 
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. [JOURNAL ARTICLE]
J Antimicrob Chemother 2008 Nov 25.
Abstract | Full CitationEarly antiretroviral therapy and mortality among HIV-infected infants.http://www.unboundmedicine.com/medline/ebm/record/19020325/full_citation/Early_antiretroviral_therapy_and_mortality_among_HIV_infected_infants_Violari A, Cotton MF, Gibb DM, et al. 
Early antiretroviral therapy and mortality among HIV-infected infants. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
N Engl J Med 2008 Nov 20; 359(21):2233-44.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.http://www.unboundmedicine.com/medline/ebm/record/19010684/full_citation/Synthesis_and_in_vitro_activities_of_a_new_antiviral_duplex_drug_linking_Zidovudine__AZT__and_Foscarnet__PFA__via_an_octadecylglycerol_residue_Schott H, Hamprecht K, Schott S, et al. 
Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue. [JOURNAL ARTICLE]
Bioorg Med Chem 2008 Nov 5.
Abstract | Full CitationLymphatic targeting of zidovudine using surface-engineered liposomes.http://www.unboundmedicine.com/medline/ebm/record/19005941/full_citation/Lymphatic_targeting_of_zidovudine_using_surface_engineered_liposomes_Kaur CD, Nahar M, Jain NK 
Lymphatic targeting of zidovudine using surface-engineered liposomes. [Journal Article]
J Drug Target 2008 Dec; 16(10):798-805.
Abstract | Full Citation | Find Related Articles Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?http://www.unboundmedicine.com/medline/ebm/record/19005271/full_citation/Does_short_term_virologic_failure_translate_to_clinical_events_in_antiretroviral_naïve_patients_initiating_antiretroviral_therapy_in_clinical_practiceMugavero MJ, May M, Harris R, et al. 
Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.]
AIDS 2008 Nov 30; 22(18):2481-92.
Abstract | Full Citation | Find Related Articles HIV Type 1 Subtype C Drug Resistance among Pediatric and Adult South African Patients Failing Antiretroviral Therapy.http://www.unboundmedicine.com/medline/ebm/record/19000027/full_citation/HIV_Type_1_Subtype_C_Drug_Resistance_among_Pediatric_and_Adult_South_African_Patients_Failing_Antiretroviral_Therapy_Pillay V, Pillay C, Kantor R, et al. 
HIV Type 1 Subtype C Drug Resistance among Pediatric and Adult South African Patients Failing Antiretroviral Therapy. [JOURNAL ARTICLE]
AIDS Res Hum Retroviruses 2008 Nov 11.
Abstract | Full CitationToxicities Associated with Dual Nucleoside Reverse-Transcriptase Inhibitor Regimens in HIV-Infected Children.http://www.unboundmedicine.com/medline/ebm/record/19000014/full_citation/Toxicities_Associated_with_Dual_Nucleoside_Reverse_Transcriptase_Inhibitor_Regimens_in_HIV_Infected_Children_Van Dyke RB, Wang L, Williams PL 
Toxicities Associated with Dual Nucleoside Reverse-Transcriptase Inhibitor Regimens in HIV-Infected Children. [Journal Article]
J Infect Dis 2008 Dec 1; 198(11):1599-608.
Abstract | Full Citation | Publisher Full Text | Find Related Articles